FIELD: medicine.
SUBSTANCE: invention refers to medicine and aims at treating arthrological diseases. Composition contains a combination of sodium chondroitin sulphate and dalargin as an active ingredient, sodium disulphite, sodium sulphite, methylparaben, trilon B and sodium hydroxide as auxiliary substances, with the following content of components, mg: sodium chondroitin sulphate 85–115 mg; dalargin 0.5–1.5 mg; sodium disulphite 0.5–5.0 mg; sodium sulphite 0.05–0.5 mg; methylparaben 0.1–0.6 mg; trilon B 0.1–0.6 mg; sodium hydroxide to pH 6.5–7.5; water for injections up to 1 ml.
EFFECT: invention provides improved pharmacological action in treating arthrological diseases, reduced side effects and maintained stability during the whole storage life of the preparation.
1 cl, 3 ex
